Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?

Colorectal cancer (CRC) is the third most commonly diagnosed malignancy worldwide and is responsible as one of the main causes of mortality in both men and women. Despite massive efforts to raise public awareness on early screening and significant advancements in the treatment for CRC, the majority...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hidayati Husainy Hasbullah, Marahaini Musa
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
p53
Acceso en línea:https://doaj.org/article/b4a1bfebaeec44c18aa6dfaa0dbf5002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!